Treatment-Related Toxicity Occurring up to 12 Weeks After Treatment Cessation
| Toxicity | Grade 1 | Grade 2 | Grade 3 | Grade 4 |
| Dry mouth | 29 (58%) | 4 (8%) | 0 (0%) | 0 (0%) |
| Lymphocytopenia | 7 (14%) | 13 (26%) | 16 (32%) | 0 (0%) |
| Thrombocytopenia | 11 (22%) | 3 (6%) | 4 (8%) | 1 (2%) |
| Fatigue | 15 (30%) | 3 (6%) | 1 (2%) | 0 (0%) |
| Nausea | 20 (40%) | 4 (8%) | 0 (0%) | 0 (0%) |
| Anemia | 3 (6%) | 6 (12%) | 5 (10%) | 0 (0%) |
| Neutropenia | 6 (12%) | 6 (12%) | 3 (6%) | 0 (0%) |
| Bone pain | 5 (10%) | 4 (8%) | 0 (0%) | 0 (0%) |
| Vomiting | 11 (22%) | 2 (4%) | 0 (0%) | 0 (0%) |
| Anorexia | 8 (16%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Dry eyes | 4 (8%) | 1 (2%) | 0 (0%) | 0 (0%) |
| Renal injury | 4 (8%) | 1 (2%) | 0 (0%) | 0 (0%) |
| Weight loss | 3 (6%) | 1 (2%) | 0 (0%) | 0 (0%) |
Possibly, probably, or definitely related treatment-emergent adverse events were graded with Common Terminology Criteria for Adverse Events, version 4.03.